Desk›Healthcare› Rubicon Research Ltd
Rubicon Research Ltd
BSE 544578 · NSE RUBICON · ISIN INE506V01022 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,805.80
-1.95%
BSE close, 28 August 2026
₹29,891.75 cr
16.6 cr shares · Mid cap
₹11,968.51 cr
as published
126.8× · —
EPS ₹14.24 · BV —
1,306.08 / 188.17
₹ cr, as filed
28
5 selected · 18%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -4.8% |
|---|---|
| Against 52-week low | +216.3% |
| Day change | -1.95% |
| Size band | Mid cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹14.24 |
|---|---|
| Price / earnings | 126.81× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 29.75% |
| Net margin | 19.28% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 427.73 | 82.45 | 4.99 | 29.75% | 19.28% |
| Mar-26 · Q | 389.88 | 70.02 | 4.25 | 28.15% | 17.96% |
| FY25-26 | 1,306.08 | 188.17 | 11.83 | 24.61% | 14.41% |
Quarter on quarter
- Revenue, quarter on quarter
- +9.7%
- Net profit, quarter on quarter
- +17.8%
- Operating margin, quarter on quarter
- +160 bps
Disclosure profile 28 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 8 |
| AGM / EGM | 3 |
| Annual Report | 2 |
| ESOP Allotment | 2 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Newspaper Publication | 1 |
| Record Date | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 23 |
| Total | 28 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
28 filings · 5 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-08-142026-10-09
SelectedProcedural
Filings
28 in the window · 3 earlier on record
-
9 October 2026 ·
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -US FDA Inspection Of The Company's Manufacturing Facility In Satara, Maharashtra, India.
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection of the Company's manufacturing facility in Satara, Maharashtra, India
Company Update / General View filing →
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
8 October 2026 ·
Allotment of ESOP / ESPS
Intimation under Regulation 30 of the SEBI (Listing Obligations and Dislcosure Requirements) Regulatoins 2015, (SEBI Listing Regulations) ESOP alottment
Company Update / Allotment of ESOP / ESPS View filing →
-
28 September 2026 ·
Closure of Trading Window
Intimation of Trading Window Closure
Insider Trading / SAST / Closure of Trading Window View filing →
-
27 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for General Atlantic Singapore RR Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
26 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results along with the Scrutinizers Report of the 27th Annual General Meeting of the Company, held on Wednesday, 26th August 2026.
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of the Proceedings of the 27th Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
19 August 2026 ·
Earnings Call Transcript
Trascript of Earnings Call Q1 FY 2026-27
Company Update / Earnings Call Transcript View filing →
-
14 August 2026 ·
Audio Recording Of Earnings Conference Call For The Quarter Ended 30Th June, 2026.
Audio Recording of earnings conference call for the quarter ended 30th June, 2026
Company Update / General View filing →
-
14 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the Quarter ended June 30, 2026.
Company Update / Monitoring Agency Report View filing →
-
14 August 2026 ·
Change in Management
Disclosure under Regulation 30 (SEBI LODR) Outcome of Board Meeting
Company Update / Change in Management View filing →
-
14 August 2026 ·
-
14 August 2026 ·
Board Meeting Outcome for Unaudited Financials Results For Quarter Ended June 30, 2026
Unaudited Financials Results for Quarter ended June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026 ·
Reg. 34 (1) Annual Report.
Corrigendum to the Integrated Annual Report for the financial year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
11 August 2026 ·
Reg. 34 (1) Annual Report.
Notice of 27th Annual General Meeting along with the Intergrated Annual report for FY 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
7 August 2026 ·
-
7 August 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026
Rubicon Research Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve The Un-Audited Standalone ....
Board Meeting / Board Meeting View filing →
-
4 August 2026 ·
Newspaper Publication
Newspaper Advertisment titled Notice of the 27th Annual General Meeting and voting Information
Company Update / Newspaper Publication View filing →
-
3 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainabilty Report for the Financial Year 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
3 August 2026 ·
Notice Of 27Th Annual General Meeting Along With Integrated Annual Report Of The Company For The Financial Year 2025-26 And Letter For Weblink To Access Notice And The Integrated Annual Report
Notice of 27th Annual General Meeting along with Integrated Annual Report of the Company for the financial year 2025-26 and Letter for weblink to access Notice and the Integrated Annual Report
AGM/EGM / AGM View filing →
-
30 July 2026 ·
Newspaper Advertisement Titled 'Information Regarding 27Th Annual General Meeting To Be Held Through Video Conferencing/ Other Audio-Visual Means, Final Dividend And Record Date Information
Newspaper ADvertisement titled "Information Regarding 27th Annual General Meeting to be held through Video Conferencing/Other Audio-Visual Means, Final Dividend and Record Date Intimation
Company Update / General View filing →
-
29 July 2026 ·
Communication On Tax Deduction At Source On Dividend
Communication on tax deduction at source on Dividend
Company Update / General View filing →
-
22 July 2026 ·
Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023
Filing of Scheme of Merger of KIA Health Tech Pvt Ltd (WOS) with Rubicon Research Limited - for Disclosure Purposes Only, in terms of the Exemption under Para 4 of SEBI Master circular ....
Company Update / General View filing →
-
22 July 2026 ·
Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023
Filing of Scheme of Merger of KIA Health Tech Private Limited (WOS) with Rubicon Research Limited - for disclosure purposes only, in terms of the Exemption under Para 4 of SEBI Master Circular ....
Company Update / General View filing →
-
22 July 2026 ·
Press Release / Media Release
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 ('SEBI Listing Regulations') - Acquisition of a Manufacturing Facility in USA.
Company Update / Press Release / Media Release View filing →
-
20 July 2026 ·
Record Date For Payment Of Final Dividend - Friday, August 7, 2026
Date of 27th AGM and Record date for payment of final dividend.
Corp. Action / Record Date View filing →
-
20 July 2026 ·
Outcome Of Board Meeting
1. Date of 27th AGM and Record date for payment of final dividend for FY 2025-26. 2. Update on merger of KIA Health Tech Private Limited, WOS with Rubicon Research Ltd.
Company Update / General View filing →
-
20 July 2026 ·
RSS feed for Rubicon Research Ltd · the 50 most recent filings